SYH2059 TABLETS OBTAINS CLINICAL TRIAL APPROVAL IN U.S. BY US FDA
Further company coverage: 1093.HK
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.